Under a newly signed partnership, AGC Pharma Chemicals and CatSci will combine to offer the former’s expertise in GMP manufacturing from development and manufacturing through to commercial with the latter’s in chemical development, analytical development, crystallisation and solid form, pre-formulation and HPAPI capabilities.
Following two years of construction work, CDMO Siegfried has officially opened its new development centre for drug products at its sites in Barberà del Vallès and El Masnou near Barcelona. About 40 specialist scientists will work there.
The centre features laboratories and pilot capacities, including dedicated facilities for highly potent oral solid dosage forms. Siegfried said that the opening also completes the successful integration of the two sites into its network. It originally acquired them from Novartis in 2020.
Dr Anahita Khanlari, industry marketing director, chemicals, at AspenTech, looks at how digitalisation can expedite the journey towards circularity
Speciality chemicals manufacturer Solenis has agreed to buy cleaning, infection prevention and hygiene giant Diversey. The $4.6 billion all-cash deal should be completed in 2H, subject to approval by Diversey shareholders, and will remove Diversey from public ownership. Both boards have backed it.
An EU-wide project by ECHA’s Enforcement Forum carried out in 2021 has found that most users of substances of commonly controlled very high concern (SVHCs), mainly SMEs, already comply with the authorisation requirement to control risks.
The authorities of all 28 member countries undertook 690 inspections at 516 companies, mostly SVHCs. The most common SVHCs checked were chromium trioxide and strontium chromate, which are used mainly in surface treatment and chrome plating.
Bachem has signed a new framework agreement to provide large volumes of peptides to an unnamed customer following a joint development project. This covers “a committed volume at an equivalent value of over CHF 500 million for the five-year period of 2027-2031, with significant upside potential,” the company said.
This follows recent deals a previous large-volume contract for another unnamed customer worth CHF 175 million in 2023-4. The deal was announced in September 2022 and subsequently upgraded with a further work order for a minimum total of CHF 1 billion from 2025 to 2029.
Cabot has announced plans for a new technology centre in Münster, Germany, which will focus on technical collaboration with customers on its battery material product lines for electric vehicles (EVs). This is due to begin operations by April 2023, with a planned expansion to be completed in 2024.
